Breadcrumb
- Home
- Frequently Asked Questions
- Audits FAQs
Audits FAQs
Responses to commonly asked questions related to MDSAP Audits.
Sidebar navigation
FAQs
- General FAQs
- Assessments FAQs
-
Audits FAQs
- How can a manufacturer participate in the MDSAP?
- Does the MDSAP add requirements for the manufacturer?
- How does the MDSAP ensure medical devices are manufactured in accordance with multiple regulations?
- How does MDSAP ensure effort is not duplicated for manufacturers that sell in multiple jurisdictions?
- Does the audit process include daily review of areas of concern?
- Are MDSAP audits conducted by single or multiple auditors?
- Who assigns a particular auditor?
- Do manufacturers seeking certification need to comply with regulations in a jurisdiction where they do not market?
- Can MDSAP RAs void any audits by an AO due to inadequate audit method?
- If an AO issues a negative final report, can the manufacturer still sell in MDSAP jurisdictions?
- How do manufacturers show they have been successfully audited under the MDSAP?
- If a manufacturing site is already under regulatory action with an MDSAP RA, can they participate in the MDSAP?
- What happens to a manufacturer when the AO recognition is revoked?
- Can non-participating RAs have access to MDSAP audit reports? How can the veracity of certificates be confirmed?
- Is the CE certification included in the outcome of a successful MDSAP audit?
- What is the definition of a "campus" in the context of multi-site QMS audits?
- What is the primary benefit of the "campus" concept for multi-site organizations?
- Do audit tasks have to be repeated during a multi-site audit?
- How should AOs treat organizations with a legal address with no association to the company’s daily operations?
- Should a remote-audited facility be included on the certificate?
- How should AOs treat “virtual” manufacturers?
- How should AOs apply the audit approach when sites are not responsible for all QMS activities?
- When should AOs employ technical experts for audits?
- Under what circumstances would an MDSAP audit be followed by an RA inspection?
- Why have the MDSAP RAs imposed an initial response period of 15 calendar days?
- What are the requirements for transfer of certification for manufacturers?
- How long can an MDSAP certificate reference a jurisdiction where no product is distributed?
- Can the manufacturer exclude a jurisdiction or products from the scope of an MDSAP audit?
- What constitutes a counterfeit medical device or a fraudulent activity requiring notification of RAs?
- What is the expectation for Class I medical device manufacturers participating in the MDSAP?
- Glossary
Information on how to contact an MDSAP AO.
Information on the MDSAP Audit Approach requirements.
Information on the MDSAP’s coverage of medical device regulations.
Information on the MDSAP’s Audit Approach process.
Information to be provided medical device manufacturers during the audit process.
Information on how audit time and the number of auditors required is determined.
Information on how auditors are assigned.
Information on jurisdictions where manufacturers need to be compliant with regulations.
Information on MDSAP and RA audit mechanisms, including special audits.
Information on RA action when a manufacturer has not met QMS or other regulatory requirements.
Information on issue of MDSAP certification documents.
Information on MDSAP participation for manufacturers under regulatory action.
Information on contracting with another MDSAP AO and MDSAP RA considerations.
Information on how non-participating RAs can access MDSAP audit reports and verify MDSAP certificates.
Information on European requirements and MDSAP Audit Approach.
The definition of a “campus” under the MDSAP.
Information on main benefit of the “campus” concept.
Information on audit tasks undertaken during multi-site audits.
Information on application of the MDSAP Audit Approach to dispersed site responsibilities.
Information on sites able to be recorded on the MDSAP certificates.
Information on audits of “virtual” manufacturers.
Information on application of the MDSAP Audit Approach to dispersed site responsibilities.
Information on MDSAP AO engagement of technical expert.
Information on when an RA inspection may be required.’
Information on the requirement for an initial response period.
Information on transfer guidelines and other resources
Information on the period to reference a jurisdiction where no product is distributed.
Information on the exclusion of a jurisdiction or products from the MDSAP audit scope.
Definitions for counterfeit medical device and fraudulent activity requiring RA notification.
Information on the activities/processes, products or facilities that are eligible for exclusion from the MDSAP.